Funding for this research was provided by:
Manchester Biomedical Research Centre (IS-BRC-1215-20007)
Article History
Received: 22 December 2020
Accepted: 20 April 2021
First Online: 5 May 2021
Declarations
:
: No ethics approval was required. The study is part of a wider ABACus project registered on the PROSPERO database (CRD42017079621). Data access was approved by the NCI (Project: PLCO-339). Participants consented at the beginning of the trial for their data to be used in approved projects. Data was de-identified to meet the requirements of HIPAA regulations.
: Not applicable
: AGR has received lecture honoraria from Merck Serona and Janssen-Cilag, and independent research funding and lecture honoraria from Novo Nordisk and Sanofi Pasteur MPS, unrelated to this study. All other authors have no conflicts of interest to declare.